Skip to content

Clinical trials

Phase 4 Schizophrenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Phase: Phase 4 Clear all

448 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20009
200115
20026
200333
200428
200537
200638
200727
200837
200926
201022
201116
201218
201313
201415
201512
20169
201710
201810
201911
20202
20217
20226
20237
20248
20256
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed331
Unknown status48
Terminated37
Recruiting15
Withdrawn9
Not yet recruiting7
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company16
Massachusetts General Hospital16
AstraZeneca10
University of California, Los Angeles10
University of Maryland, Baltimore10
Janssen Korea, Ltd., Korea9
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.9
Shanghai Mental Health Center8
North Suffolk Mental Health Association7
Northwell Health7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia448
Psychotic Disorders183
Bipolar Disorder27
Metabolic Syndrome16
Diabetes Mellitus12
Mental Disorders11
Substance-Related Disorders9
Alcoholism8
Cognitive Dysfunction8
Insulin Resistance8

Trials

Showing 26 to 50 of 448. Each trial links to its page on Pharma Observatory.

348 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.